Tsuji M, Ito Y, Terada N, Mori H
Department of Pathology, Osaka Medical College, Takatsuki, Japan.
Acta Endocrinol (Copenh). 1989 Oct;121(4):595-602. doi: 10.1530/acta.0.1210595.
Osteogenic disorder syndrome rats are unable to synthesize ascorbic acid owing to the lack of l-gulonolactone oxidase, and become scorbutic within a few weeks without the supply of ascorbic acid. We studied effects of ascorbic acid deficiency on the ovarian aromatase activity in vivo using osteogenic disorder syndrome rats. The ovarian aromatase activity in ascorbic acid-deficient osteogenic disorder syndrome rats was significantly higher than that in normal or ascorbic acid-supplied osteogenic disorder syndrome rats. The activity in hypophysectomized immature rats was extremely low, but increased after treatment with pregnant mare serum gonadotropin, regardless of the presence or absence of ascorbic acid. The extent of the increase was the same among experimental groups. The present results indicate that ascorbic acid at physiological level lowers the ovarian aromatase activity, whereas it does not impair the responsiveness of the aromatase activity to gonadotropins.
成骨不全综合征大鼠由于缺乏L-古洛糖酸内酯氧化酶而无法合成抗坏血酸,在没有抗坏血酸供应的情况下,几周内就会患坏血病。我们使用成骨不全综合征大鼠研究了抗坏血酸缺乏对体内卵巢芳香化酶活性的影响。抗坏血酸缺乏的成骨不全综合征大鼠的卵巢芳香化酶活性显著高于正常或补充抗坏血酸的成骨不全综合征大鼠。垂体切除的未成熟大鼠的活性极低,但在用孕马血清促性腺激素治疗后增加,无论是否存在抗坏血酸。实验组之间增加的程度相同。目前的结果表明,生理水平的抗坏血酸会降低卵巢芳香化酶活性,而不会损害芳香化酶活性对促性腺激素的反应性。